3.2.0.0 Op­ti­miz­ing Self-‍mon­i­tor­ing of Blood Glu­cose and Con­tin­u­ous Glu­cose Mon­i­tor Use

SMBG and CGM ac­cu­ra­cy is de­pen­dent on the in­stru­ment and user, so it is im­por­tant to eval­u­ate each pa­tient’s mon­i­tor­ing tech­nique, both ini­tially and at reg­u­lar in­ter­vals there­after. Op­ti­mal use of SMBG and CGM re­quires prop­er re­view and in­ter­pre­ta­tion of the data, by both the pa­tient and the pro­vider, to en­sure that data are used in an ef­fective and time­ly man­ner. For pa­tients with type 1 di­a­betes using CGM, the great­est pre­dic­tor of A1C low­er­ing for all age-‍groups was fre­quen­cy of sen­sor use, which was high­est in those aged ≥25 years and lower in younger age-‍groups (41). Sim­i­lar­ly, for SMBG in pa­tients with type 1 di­a­betes, there is a cor­re­la­tion be­tween greater SMBG fre­quen­cy and lower A1C (42). Among pa­tients who check their blood glu­cose at least once daily, many re­port tak­ing no ac­tion when re­sults are high or low (43). Pa­tients should be taught how to use SMBG and/‍or CGM data to ad­just food in­take, ex­er­cise, or phar­ma­co­log­ic ther­a­py to achieve specific goals. The on­go­ing need for and fre­quen­cy of SMBG should be reeval­u­ated at each rou­tine visit to avoid overuse, par­tic­u­larly if SMBG is not being used ef­fec­tive­ly for self-man­agement (43–45).